Thay thế van hai lá qua ống thông cho van sinh học hai lá bị thoái hóa, thất bại trong phẫu thuật van hai lá và van tự nhiên với xơ hóa vòng van hai lá nghiêm trọng: một đánh giá hệ thống và phân tích tổng hợp

Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254–743.

Goldstone AB, Chiu P, Baiocchi M, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med. 2017;377(19):1847–57.

Mohty D, Orszulak TA, Schaff HV, Avierinos JF, Tajik JA, Enriquez-Sarano M. Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation. 2001;104:I1–7.

Beute TJ, Goehler M, Parker J, Boeve T, Heiser J, Murphy E, Timek T, Willekes CL. Long-term outcomes of mosaic versus perimount mitral replacements: 17-year follow-up of 940 implants. Ann Thorac Surg. 2020;110:508–15.

David TE, Armstrong S, McCrindle BW, Manlhiot C. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation. 2013;127:1485–92.

Lazam S, Vanoverschelde JL, Tribouilloy C, Grigioni F, Suri RM, Avierinos JF, De MC, Barbieri A, Rusinaru D, Russo A, et al. Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: analysis of a large, prospective, multicenter. International Registry Circulation. 2017;135:410–22.

Albeyoglu SC, Filizcan U, Sargin M, Cakmak M, Goksel O, Bayserke O, Cinar B, Eren E. Determinants of hospital mortality after repeat mitral valve surgery for rheumatic mitral valve disease. Thorac Cardiovasc Surg. 2006;54:244–9.

Jamieson WR, Burr LH, Miyagishima RT, Janusz MT, Fradet GJ, Lichtenstein SV, Ling H. Reoperation for bioprosthetic mitral structural failure: risk assessment. Circulation. 2003;108(Suppl 1):II98–102.

Vohra HA, Whistance RN, Roubelakis A, Burton A, Barlow CW, Tsang GM, Livesey SA, Ohri SK. Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience. Interact Cardiovasc Thorac Surg. 2012;14:575–9.

Toker ME, Eren E, Guler M, Kirali K, Yanartas M, Balkanay M, Yakut C. Second and third cardiac valve reoperations: factors influencing death and long-term survival. Tex Heart Inst J. 2009;36:557–62.

Expósito V, García-Camarero T, Bernal JM, Arnáiz E, Sarralde A, García I, Berrazueta JR, Revuelta JM. Repeat mitral valve replacement: 30-years’ experience. Rev Esp Cardiol. 2009;62:929–32.

Webb JG, Cheung AW, Dvir D. Transcatheter mitral valve replacement when mitral surgery fails: 10 years later. J Am Coll Cardiol. 2017;70(9):1132–4.

Dvir D, Webb JG. Mitral valve-in-valve and valve-in-ring: technical aspects and procedural outcomes. EuroIntervention. 2016;12:93–6.

Grover FL, Vemulapalli S, Carroll JD, et al. 2016 annual report of the society of thoracic surgeons/American College of Cardiology transcatheter valve therapy registry. J Am Coll Cardiol. 2017;69(10):1215–30.

Paradis JM, Del Trigo M, Puri R, Rodes- CJ. Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical prosthetic dysfunction. J Am Coll Cardiol. 2015;66:2019–37.

Yoon S-H, Whisenant BK, Bleiziffer S, et al. Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings. J Am Coll Cardiol. 2017;70:1121–31.

Cheung A, Webb JG, Wong DR, et al. Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg. 2009;87:18–20.

de Weger A, Ewe SH, Delgado V, et al. First-in-man implantation of a trans-catheter aortic valve in a mitral annuloplasty ring: novel treatment modality for failed mitral valve repair. Eur J Cardiothorac Surg. 2011;39:1054–6.

Guerrero M, Urena M, Himbert D, et al. 1-Year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol. 2018;71(17):1841–53.

Yoon SH, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40(5):441–51.

Vohra HA, Whistance RN, Bezuska L, Livesey SA. Surgery for non-rheumatic calcific mitral stenosis. J Heart Valve Dis. 2011;20:624–6.

Casarotto D, Bortolotti U, Thiene G, Gallucci V, Cévese PG. Rupture of the posterior wall of the left ventricule after replacement of the mitral valve: a description of 8 cases (author’s transl). G Ital Cardiol. 1977;7:387–94.

Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.

Wells G. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. In: Symposium on systematic reviews: beyond the basics. 2014.

Eleid MF, Whisenant BK, Cabalka AK, et al. Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv. 2017;10(19):1932–42.

Hu J, Chen Y, Cheng S, et al. Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: a systematic review and meta-analysis. J Card Surg. 2018;33(9):508–19.

Tiwana J, Aldea G, Levin DB, et al. Contemporary transcatheter mitral valve replacement for mitral annular calcification or ring. JACC Cardiovasc Interv. 2020;13(20):2388–98.

Guerrero M, Vemulapalli S, Xiang Q, et al. Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the united states: data from the society of thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv. 2020;13(3):e008425.

Simonato M, Whisenant B, Ribeiro HB, Webb JG, Kornowski R, Guerrero M, Wijeysundera H, Søndergaard L, De Backer O, et al. Transcatheter mitral valve replacement after surgical repair or replacement: comprehensive midterm evaluation of valve-in-valve and valve-in-ring implantation from the VIVID registry. Circulation. 2021;143:104–16.

Sterne JA, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323(7304):101–5.

Praz F, Khalique OK, Lee R, et al. Transatrial implantation of a transcatheter heart valve for severe mitral annular calcification. J Thorac Cardiovasc Surg. 2018;156(1):132–42.

Guerrero M, Dvir D, Himbert D, et al. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. JACC Cardiovasc Interv. 2016;9(13):1361–71.

Kanjanauthai S, Nasir K, Katz R, et al. Relationships of mitral annular calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2010;213(2):558–62.

Chan V, Ruel M, Hynes M, Chaudry S, Mesana TG. Impact of mitral annular calcification on early and late outcomes following mitral valve repair of myxomatous degeneration. Interact Cardiovasc Thorac Surg. 2013;17(1):120–5.

Maisano F, Taramasso M. Mitral valve-in-valve, valve-in-ring, and valve-in-MAC: the good, the bad, and the ugly. Eur Heart J. 2019;40(5):452–5.

Massera D, Trivieri MG, Andrews JPM, et al. Disease activity in mitral annular calcification. Circ Cardiovasc Imaging. 2019;12(2):e008513.

Boon A, Cheriex E, Lodder J, et al. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart. 1997;78:472–4.

Nair CK, Sudhakaran C, Aronow WS, et al. Clinical characteristics of patients younger than 60 years with mitral anular calcium: comparison with age- and sex-matched control subjects. Am J Cardiol. 1984;54:1286–7.

Lamelas J, Alnajar A. Early outcomes for surgical minimally invasive SAPIEN 3 transcatheter mitral valve replacement. Ann Thorac Surg. 2020;112:494–500.

Eleid MF, Cabalka AK, Williams MR, et al. Percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv. 2016;9(11):1161–74.

Nazir S, Lohani S, Tachamo N, et al. Outcomes following transcatheter transseptal versus transapical mitral valve-in-valve and valve-in-ring procedures. J Cardiovasc Thorac Res. 2018;10(4):182–6.

Dvir D. Transseptal instead of transapical valve implantation: making mitral great again? JACC Cardiovasc Interv. 2016;9:1175–7.

Wang DD, Eng MH, Greenbaum AB, et al. Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR). Catheter Cardiovasc Interv. 2018;92:379–87.

Khan JM, Babaliaros VC, Greenbaum AB, et al. Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement. J Am Coll Cardiol. 2019;73:2521–34.

Harloff MT, Chowdhury M, Hirji SA, et al. A step-by-step guide to transseptal valve-in-valve transcatheter mitral valve replacement. Ann Cardiothorac Surg. 2021;10(1):113–21.

Wang DD, Guerrero M, Eng MH, et al. Alcohol septal ablation to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: first-in-man study. JACC Cardiovasc Interv. 2019;12(13):1268–79.

Babaliaros VC, Greenbaum AB, Khan JM, et al. Intentional percutaneous laceration of the anterior mitral leaflet to prevent outflow obstruction during transcatheter mitral valve replacement: first-in-human experience. JACC Cardiovasc Interv. 2017;10:798–809.

Khan JM, Babaliaros VC, Greenbaum AB, et al. Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement [published correction appears in J Am Coll Cardiol. 2019 Jul 30;74(4):595]. J Am Coll Cardiol. 2019;73(20):2521–34.